Advances in basic and clinical research on hepatocellular carcinoma in 2016
10.3760/cma.j.issn.1007-3418.2017.02.002
- VernacularTitle: 2016年肝癌基础与临床研究进展
- Author:
Zhizhen DONG
1
;
Xiaodong ZHU
2
;
Zhao LI
3
;
Yuge MAO
3
;
Yuelong CHAI
4
;
Dengfu YAO
1
;
Huichuan SUN
2
;
Jiye ZHU
3
;
Kuansheng MA
4
Author Information
1. Affiliated Hospital of Nantong University, Nantong Jiangsu Province 226001, China
2. Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
3. Department of Hepatobiliary Surgery, Key Laboratory of Liver Cirrhosis and Cancer in Beijing, People’s Hospital, Peking University, Beijing 100044, China
4. Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing 400038, China
- Publication Type:Journal Article
- Keywords:
Carcinoma, hepatocellular;
Diagnosis;
Therapeutics;
Molecular marker;
Robert;
Radiofrequency ablation
- From:
Chinese Journal of Hepatology
2017;25(2):85-93
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma (HCC) is still one of common malignant cancers worldwide, with increasing incidence and mortality rates. Early diagnosis and effective treatment for HCC remain to be explored. This article introduces the research advances in the early specific diagnosis and effective therapies for HCC in 2016, such as molecular markers in the specific diagnosis and targeted therapy for HCC, main therapeutic regimens, robot-assisted liver resection, and no-touch radiofrequency ablation.
